| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5641805 | ALCON LABS INC | Topical ophthalmic formulations for treating allergic eye diseases |
Jun, 2015
(8 years ago) | |
|
US5641805 (Pediatric) | ALCON LABS INC | Topical ophthalmic formulations for treating allergic eye diseases |
Dec, 2015
(8 years ago) | |
Pataday Twice Daily Relief is owned by Alcon Labs Inc.
Pataday Twice Daily Relief contains Olopatadine Hydrochloride.
Pataday Twice Daily Relief has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Pataday Twice Daily Relief are:
- US5641805
- US5641805*PED
Pataday Twice Daily Relief was authorised for market use on 18 December, 1996.
Pataday Twice Daily Relief is available in solution/drops;ophthalmic dosage forms.
Pataday Twice Daily Relief can be used as treating allergic eye diseases in humans.
The generics of Pataday Twice Daily Relief are possible to be released after 06 December, 2015.
Drugs and Companies using OLOPATADINE HYDROCHLORIDE ingredient
Market Authorisation Date: 18 December, 1996
Treatment: Treating allergic eye diseases in humans
Dosage: SOLUTION/DROPS;OPHTHALMIC
PATADAY TWICE DAILY RELIEF family patents
